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Abstract
Allophenic mice, supposedly containing almost equal numbers of cells derived from
embryos of mouse strains C57Bl and FVB, were shown in a recent paper to grow the
B16 melanoma, a long transplanted tumor of C57Bl origin, much better than did
mice of either the parental C57Bl strain or the C57Bl × FVB F1 hybrid. Mice contain-
ing smaller proportions of C57Bl cells rejected the tumor. A reconsideration of these
suprising data, in light of the current literature, suggests that the better growth of
the tumor in the 50-50% allophenics than in the C57Bl parental strain was almost
certainly caused by the tumor stimulation engendered by a weak anti-C57Bl immune
reaction in the overtly healthy allophenic mice.
Background
The allophenic mouse, as described by Mintz and Silvers [1], resulted from allowing
two embryos of different inbred strains to fuse in vitro and then, upon implantation
into a surrogate mother, grow into an adult. The adult allophenic mice were of normal
size and had no obvious autoimmune problems. In the recent study by Wagner et al.,
that is the subject of the present paper, allophenic mice appeared overtly to be as
immunologically tolerant to self as were inbred mice of either of the parental strains
[2]. In the particular study by Wagner et al., one of the parental strains used was
C57Bl. In some cases, varying numbers of C57Bl cells, from eight cell-stage embryos,
were aggregated with whole FVB strain embryos, also at the eight cell-stage, to create
“embryo-aggregated” chimeric mice with varying proportions of C57Bl cells. A rough
idea of the the proportion of C57Bl cells surviving in these chimeric adults could be
gained by observing the degree of black coloration of the skin. Rather than using grafts
of normal C57Bl tissue to test the anti-C57Bl immune capacities of the aggregated and
allophenic animals, the authors used as a surrogate the B16 melanoma, a long trans-
planted tumor that had originated in the C57Bl strain. This resulted in a seemingly
remarkable discovery, a discovery that instigated the present paper [2].
It was found that B16 tumors, implanted s.c., grew significantly faster in allophenic
mice with full chimerism in their skins as compared with the tumor’s growth in either
syngeneic C57Bl or semi-syngeneic C57Bl × FVB F1 hosts. In contrast, tumor growth
was either absent or significantly reduced in embryo-aggregated mice with reduced
numbers of or lacking C57Bl-derived cells in their skin, but tolerant to C57Bl tissue in
other organs [2]. The authors apparently found no completely satisfactory explanation
for these remarkable findings so we offer the following speculations.
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We think it very probable that there was little or no specific anti-tumor immunity; in
any case, the tumor antigens were a constant throughout the work. Any tumor-specific
immune effects were probably overshadowed by a weak allograft immunity, a possibi-
lity suggested by the facts that tumor growth paralleled the presence or absence locally
of allogeneic C57Bl cells in the aggregated host’st i s s u e s ;t h eg r o w t ho ft h eC 5 7 B l
tumor cells was directly related to the systemic proportion of normal C57Bl cells. That
the fully allophenic mice did have some degree of subliminal anti-C57Bl autoimmunity
is supported by the work of Wegmann et al. which showed that the lymphoid cells of
an allophenic mouse reacted positively against either of the parental strains in an in-
vitro assay [3]. Furthermore, inhibition of the melanoma, when it occurred in the
aggregated mice that were deficient in C57Bl cells, did not appear to develop gradually,
but appeared to be preexisting. Thus, we assume that tumor specific immunity played
no significant role in the observations of Wagner et al. [2] It is apparent that the anti-
C57Bl allograft immunity was very weak or the mice could probably not have appeared
to be healthy.
How is it that, in the work of Wagner et al, the C57Bl melanoma grew better in fully
chimeric allophenic mice than it did in inbred C57Bl parental strain animals or in the
appropriate F1 hybrids?
If the anti-C57Bl immune reaction were, counter intuitively, less in the allophenic
than in the parental anti-C57Bl, the better tumor growth in the allophenic would need
no further explanation. However, among the various embryo-aggregated mice, as the
proportion of C57Bl cells increased (and the proportion of FVB cells decreased) the
level of immune resistance to the growth of C57Bl cells steadily decreased. One would
logically infer that the anti-C57Bl immunity of the parental C57Bl, having absolutely
no FVB cells, would be less than the anti-C57Bl immunity in any of the allophenic or
embryo-aggregated mice. This being so, why did the C57Bl tumor grow better in the
presumptinely more anti-C57Bl reactive allophenic mice than it did in the mice of the
C57Bl parental strain?
That the better growth of C57Bl cells probably occurred in the mouse with greater
anti-C57Bl immune reactivity is not without precedent. We suggest that the B16
tumor grew better in the fully allophenic mice than it did in a syngeneic parent in
accord with the hormetic shape of the immune response curve (IRC); the IRC relates
the stimulation or inhibition of growth to the quantitative size of the specific immune
reaction [4]. In general, a weaker immunity has been shown to stimulate tumor growth
while a larger quantity of the same immune reactants may be inhibitory [5]. The IRC
describes the quantatative relationship between the immune reactants and the growth
of target cells, it does not explain why it happens. (See figure 1, -the IRC).
T h ec u r v e( I R C )i sl a r g e l yb a s e du p o no b s ervations made with tumor antigens; we
think, without direct evidence, that it is probably also applicable to normal allo-ant-
gens. The possible existance of a phenomenon of stimulated growth by a weak
immune reaction was first suggested by the possibility that a weak immune reaction to
a fetus may be a benefit to fetal survival [6]. Subsequently, the possibility of the
phenomenon of immunostimulation of growth was tested directly using Winn tests; a
specific number of tumor cells was mixed with various numbers of syngeneic spleen
cells harvested from mice that had either bourne or not bourne the specific tumor [4].
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shortly before, beem radiated and thymectomized in order to prevent, as far as possi-
ble, host contributions to any observed immunological effect. The results were clear.
The relationship of the quantity of immune reactants to tumor growth was not linear;
small proportions of immune spleen cells stimulated tumor growth while larger pro-
portions were inhibitory. An idealized portrayal of this result is shown in figure1.
Numerous other titrations, similar in principle, were performed by us as well as by
others both in vitro and in vivo with similar results [5]. It seems particularly evident
from titrations done with specific antibody that one and the same immune reactant
can probably be stimulatory or inhibitory depending only upon dosage [7].
In addition to the titrations described above, the phenomenon of immunostimulation
of tumor growth was further explored indirectly by observations of other types. For
example, in two large studies, each confirming the other, it was observed in mouse car-
cinogenesis studies with 3-methylcholanthrene that the tumors with the shortest
latences had intermediate levels of immunogenicity. Thus, the most conducive
immune-reaction for rapidity of tumor growth was not minimal; it was apparently a
significantly positive, albeit low, reaction [8]. Other studies consistent with the immu-
nostimulation hypothesis are outlined in [5].
In view of all this evidence, we feel that the non-linear immune reaction curve (IRC)
relating the quantity of immune reactants to the stimulation or inhibition of tumor
growth is generally correct and we feel quite comfortable in using it to help under-
stand the growth behavior of target tissues in the allophenic mice. Thus, we suggest
that the weak allograft immunity in the fully allophenic mice produced a stimulatory
reaction in the B16 melanoma compared to a lack of an immune reaction in the paren-
tal strain. (Compare, in figure 1, ‘a’, the null reaction in the parental pure strain, with
‘b’ - ‘d’, the suggested weak stimulatory reaction to tumor in the fully allophenic mice).
In contrast to the full allophenics, those with fewer C57Bl cells often refused to grow
the tumor [2]; these mice apparently had a higher degree of anti-C57Bl immunity and
fell upon an inhibitory part of the IRC (to the right of ‘e’).
In two cases, tumors that had failed to grow in the skin of an aggregated chimera
deficient in C57Bl cells were subsequently found to have grown well in underlying
internal organs [2]. This observation suggests, assuming an accurately aimed tumor
inoculum, that some unknown attribute of the skin increased the effectiveness of
immunity in that organ while the reaction elsewhere was weaker and thus still in the
Figure 1 An idealized representation of the data in citation [4] showing the non-linear effect of the
relative proportions of immune reactants on the growth of a target tumor.
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probably by both positive and negative selection, may have influenced the organ distri-
bution of the normal C57Bl cells in both the fully allophenic and the embryo aggre-
gated mice.
This analysis unfortunately sheds little light upon the nature of the mechanisms that
serve to keep autoimmunity to a harmless level. The embryo-aggregated mice pro-
duced by Wagner et al. [2] do strongly suggest that the low levels of autoimmunity
sufficient to produce tumor stimulation are probably relatively harmless to non-neo-
plastic cells with shared immunogenic specificities [2]. These mice also serve to suggest
what had been assumed, but not previously demonstrated; immunity to normal tissue
allo-antigens apparently conforms to an IRC with a non-linear shape much like the
c u r v ef o l l o w e db yt u m o r - s p e c i f i ca n t i g e n s .H o w e v e r ,t h e r ea p p e a r st ob ead i f f e r e n t i a l
between normal and tumor cells in that normal cells appear to respond to a small
immune reaction with less obvious proliferation than do tumor cells and perhaps with
a lessened inhibition by somewhat larger immune reactions.
T h ed i f f e r e n c eb e t w e e nt h ed e g r e eo fs e l f - t o l e r a n c ei naf u l l ya l l o p h e n i cm o u s ea n d
in a pure strain parent could be dependent upon the fact that the parent and the F1
mice both have a full load of immunogenic cells while the fully allophenic mouse has
only half as much, consisting as it does, of one of the two sets of parental-antigen con-
taining cells. However, it should be noted that the F1, while it presumably has half as
many antigens per cell, has a full 100% complement of immunogenic cells; apparently
it is the proportion of immunogenic cells that counts for the induction of self-toler-
ance and not the antigenic load per cell.
There is much evidence from other systems that suggest that larger antigen dosages
favor higher degrees of tolerance [9-13]. as indeed seems to be the case with the
embryo-aggregated mice. The work of Wagner et al. shows clearly that in the allophe-
nics and embryo aggregated mice the degree of self-tolerance was directly proportional
to the degree of chimerism; the fewer the C57Bl cells, the less the self-tolerance and
the greater the degree of anti-C57Bl immunity.
In contrast, it is also clear from other studies that tiny antigen dosages, as seen in
the “sneaking through phenomenon” [14] and in the relative tolerance of mice to auto-
logous tumors [15,16], can regularly produce a form of immunological tolerance to
tumor antigens. How and whether these tolerance phenomena may be related to the
self-tolerance mechanisms present in allophenics is not clear, especially since the latter
are engendered in embryos rather than in adult antigen recipients.
Conclusions
In sum, from the work of Wagner and colleagues the following conclusions seem rea-
sonable:
1). Self-tolerance in allophenics is largely a function of the proportion of cells con-
taining the self-antigens rather than the amount of immunogen per cell. The
greater the proportion of antigen containing cells, the greater the degree of
immune self-tolerance. Hence the difference between the full-allophenic and the F1
in stimulating growth of the B16 tumor.
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nic mice may sometimes be sufficient to stimulate the growth of a tumor that has
a pertinent allo-antigen. The phenomenon of tumor immunostimulation is thus
further supported [17].
3). Normal tissues respond to immunity along curves similar to the IRC except that
tumor tissue may be more overtly sensitive to immunostimulation and perhaps also
to immune inhibition.
4). Probably none of our speculations bears directly upon the role of regulatory
T-cells in self tolerance [18] or on the possibility of immune paralysis [19].
The speculations we have here advanced may well be wrong in whole or in part, but
they are internally consistent and are, as we have pointed out, congenial with many
other studies. The observations of Wagner et al. [2] are of intense interest and fascina-
tion; it is certainly satisfying to be able to fit their remarkable results somewhat into
the general body of contemporary knowledge.
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